Skip to content

Node-RADS-Based Imaging Evaluation of Pancreatic Cancer

Node-RADS-Based Imaging Evaluation of Pancreatic Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600122221
Enrollment
Unknown
Registered
2026-04-10
Start date
2026-04-15
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

Gold Standard:pathological reports and surgical records
Index test:Preoperative Node-RADS score and the corresponding model of regional lymph node and distant lymph node metastasis

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients with pancreatic cancer confirmed by postoperative pathology. 2.Patients who have undergone radical surgery for pancreatic cancer with complete surgical records. 3.Availability of complete preoperative contrast-enhanced CT examination data.

Exclusion criteria

Exclusion criteria: 1.Presence of distant metastasis. 2.An interval exceeding one month between the preoperative CT examination and the surgery. 3.Severe image artifacts that preclude reliable evaluation. 4.Missing patient survival data.

Design outcomes

Primary

MeasureTime frame
Node-RADS score;Prediction accuracy;

Secondary

MeasureTime frame
pathological reports and surgical records;

Countries

China

Contacts

Public ContactZixing Huang

West China Hospital, Sichuan University

zixinghuang@hotmail.com+86 138 8220 6874

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026